Related Experiment Video
Updated: Aug 24, 2026

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment
Published on: April 22, 2019
Inactivation patterns of p16/INK4A in oral squamous cell carcinomas
Jeong-Keun Lee1, Myung-Jin Kim, Sam-Pyo Hong
1Department of Dentistry, School of Medicine, Ajou University, Suwon 442-749, Korea. arcady@ajou.ac.kr
Abstract:
The p16/INK4A is one of the major target genes in carcinogenesis and its inactivation has frequently been reported in other types of tumors. The purpose of this study is to evaluate inactivation patterns of p16/INK4A in oral squamous cell carcinoma. Six different oral cancer cell lines, SCC-4, SCC-9, SCC-15, SCC-25, KB, and SNUDH- 379 were examined for inactivation of p16/INK4A genes. In the analysis of p16/INK4A gene inactivation, PCR amplification, direct sequencing, and methylation-specific PCR methods were adopted for evaluation of homozygous deletion, point mutation, and promoter hypermethylation, respectively. Homozygous deletion was detected in SCC-25 and SCC-9. SCC-15 showed hypermethylated promoter region within p16/INK4A gene. It is suggestive in the present study that inactivation patterns of p16/INK4A were mainly homozygous deletion, promoter methylation rather than point mutation in oral squamous cancer cell lines, so treatment modalities of oral squamous cell carcinoma should be focused on these types of inactivation.
Insights
In oral squamous cell carcinoma, the p16/INK4A gene is often inactivated through homozygous deletion or promoter methylation, not point mutation. These findings suggest targeted therapies focusing on these inactivation patterns for oral cancer treatment.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- The p16/INK4A gene is a critical target in carcinogenesis.
- Gene inactivation is a common event in various tumor types.
Purpose of the Study:
- To investigate the inactivation patterns of the p16/INK4A gene in oral squamous cell carcinoma (OSCC).
Main Methods:
- Analysis of six OSCC cell lines (SCC-4, SCC-9, SCC-15, SCC-25, KB, SNUDH-379).
- Utilized PCR amplification and direct sequencing for homozygous deletion and point mutation detection.
- Employed methylation-specific PCR to assess promoter hypermethylation.
Main Results:
- Homozygous deletion of p16/INK4A was identified in SCC-25 and SCC-9 cell lines.
- Promoter hypermethylation of p16/INK4A was observed in the SCC-15 cell line.
- Point mutations were not a primary mechanism of inactivation in the studied OSCC cell lines.
Conclusions:
- Inactivation of p16/INK4A in OSCC predominantly occurs via homozygous deletion and promoter methylation.
- These findings highlight the importance of targeting these specific inactivation mechanisms in OSCC treatment strategies.
Related Concept Videos
Inhibition of Cdk Activity
Loss of Tumor Suppressor Gene Functions
When the tumor suppressor genes develop mutations or are lost, cells start growing out of control, leading to cancer. However, a single functional copy of the tumor suppressor gene is enough for the cells to maintain their normal functions and cell...
Abnormal Proliferation
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...

